Teleflex Incorporated (NYSE:TFX - Get Free Report) Director Gretchen R. Haggerty purchased 500 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was bought at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the transaction, the director directly owned 6,305 shares in the company, valued at approximately $723,498.75. The trade was a 8.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Teleflex Price Performance
Shares of TFX stock traded up $3.35 during trading hours on Thursday, reaching $115.42. The company's stock had a trading volume of 694,762 shares, compared to its average volume of 807,305. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The firm's 50 day simple moving average is $118.48 and its 200-day simple moving average is $135.98. The company has a market capitalization of $5.10 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 1.60 and a beta of 1.08.
Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.36 by $0.37. The firm had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the company posted $3.42 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, August 15th. Teleflex's dividend payout ratio (DPR) is currently 32.00%.
Analysts Set New Price Targets
TFX has been the topic of several recent research reports. Royal Bank Of Canada lifted their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Wells Fargo & Company lowered their target price on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Truist Financial cut their target price on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Finally, Mizuho raised their price target on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $141.57.
View Our Latest Analysis on TFX
Hedge Funds Weigh In On Teleflex
A number of hedge funds have recently added to or reduced their stakes in the stock. Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 153 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after acquiring an additional 100 shares during the last quarter. Banque Cantonale Vaudoise purchased a new stake in shares of Teleflex during the 1st quarter valued at approximately $27,000. Costello Asset Management INC purchased a new stake in shares of Teleflex during the first quarter worth $28,000. Finally, Headlands Technologies LLC bought a new position in Teleflex in the 4th quarter worth about $29,000. Institutional investors and hedge funds own 95.62% of the company's stock.
Teleflex Company Profile
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.